Anhui Sunhere Pharmaceutical Excipients Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Anhui Sunhere Pharmaceutical Excipients Co Ltd with three other
pharmaceutical manufacturers in Asia:
Sci Pharmtech Inc
sales of 1.94 billion Taiwanese Dollars [US$64.62 million]
of which 62%
was Active Pharmaceutical Ingredients),
Sms Pharmaceuticals Limited
(4.63 billion Indian Rupees [US$64.87 million]
of which 100%
was Pharmaceutical), and
DOMESCO Medical Import Export Joint Stock Corp
based in Vietnam
(1.39 trillion Dong [US$59.56 million]
During the year ended December of 2018, sales at
Anhui Sunhere Pharmaceutical Excipients Co Ltd were 428.56 million Chinese Renmimbi (US$61.39 million).
increase of 26.3%
versus 2017, when the company's sales were 339.36 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Anhui Sunhere Pharmaceutical Excipients Co Ltd
(and since 2013, sales have increased a total of 101%).
Sales of Pharmacy saw an increase
26.3% in 2018, from
338.99 million Chinese Renmimbi to 428.17 million Chinese Renmimbi.